The activity of hsp90α promoter is regulated by NF-κB transcription factors

Oncogene

Volumn 27, Issue 8, 2008, Pages 1175-1178

  Ammirante, M ^a   Rosati, A ^a   Gentilella, A ^a   Festa, M ^a   Petrella, A ^a   Marzullo, L ^a   Pascale, M ^a   Belisario, M A ^a   Leone, A ^a   Turco, M C ^a  

^a UNIVERSITY OF SALERNO   (Italy)

Author keywords

Heat shock proteins; hsp90 ; NF B

Indexed keywords

HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; PHORBOL 13 ACETATE 12 MYRISTATE; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL SURVIVAL; CELLULAR STRESS RESPONSE; CONSENSUS SEQUENCE; CONTROLLED STUDY; DNA FLANKING REGION; GENE EXPRESSION; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SITE DIRECTED MUTAGENESIS;

BASE SEQUENCE; CELL LINE; CELL NUCLEUS; CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HELA CELLS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTOR RELA;

EID: 39149083699     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210716     Document Type: Article

References (14)

1. Broemer M, Krappmann D, Scheidereit C. (2004). Requirement of Hsp90 activity for IκB kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-κB activation. Oncogene 23: 5378-5386.
2. Chen G, Cao P, Goeddel DV. (2002). TNF-induced recruitment and activation of the IKK complex require Cdc37and Hsp90. Mol Cell 9: 401-410.
3. Field N, Low W, Daniels M, Howell S, Daviet L, Boshoff C et al. (2003). KSHV vFLIP binds to IKK-γ to activate IKK. J Cell Sci 116: 3721-3728.
4. Karin M, Greten FR. (2005). NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5: 749-759.
5. Maiuri MC, Tajana G, Iuvone T, De Stefano D, Mele G, Ribecco MT et al. (2004). Nuclear factor-kappaB regulates inflammatory cell apoptosis and phagocytosis in rat carrageenin-sponge implant model. Am J Pathol 165: 115-126.
6. Mitsiades CS, Mitsiades NS, McMullan CJ, Poulaki V, Kung AL, Davies FE et al. (2006). Antimyeloma activity of heat shock protein-90 inhibition. Blood 107: 1092-1100.
7. Morimoto RI, Sarge KD, Abravaya K. (1992). Transcriptional regulation of heat shock genes. A paradigm for inducible genomic responses. J Biol Chem 267: 21987-21990.
8. Pearl LH, Prodromou C. (2003). Structure and functional relationships of Hsp90. Curr Cancer Drug Targets 3: 301-323.
9. Pittet JF, Lee H, Pespeni M, O'Mahony A, Roux J, Welch WJ. (2005). Stress-induced inhibition of the NF-kappaB signaling pathway results from the insolubilization of the IkappaB kinase complex following its dissociation from heat shock protein 90. J Immunol 174: 384-394.
10. Richter K, Hendershot LM, Freeman BC. (2007). The cellular world according to Hsp90. Nat Struct Mol Biol 14: 90-94.
11. Romano MF, Lamberti A, Bisogni R, Garbi C, Pagnano AM, Auletta P et al. (1999). Amifostine inhibits hematopoietic progenitor cell apoptosis by activating NF-kappaB/Rel transcription factors. Blood 94: 4060-4066.
12. Tanaka T, Nasmyth K. (1998). Association of RPA with chromosomal replication origins requires an Mcm protein, and is regulated by Rad53, and cyclin- and Dbf4-dependent kinases. EMBO J 17: 5182-5191.
13. Whitesell L, Lindquist SL. (2005). HSP90 and the chaperoning of cancer. Nat Rev Cancer 5: 761-772.
14. Young JC, Agashe VR, Siegers K, Hartl FU. (2004). Pathways of chaperone-mediated protein folding in the cytosol. Nat Rev Mol Cell Biol 5: 781-791.